Peringkat dalam Saham
#41228
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Kapitalisasi Pasar
$33.74K
Perubahan (1 hari)
-1.49%
Perubahan (1 tahun)
-40.77%
Perdagangan GENinCode plc (GENI)
Harga GENI dengan kapitalisasi pasar B
Kapitalisasi pasar dari GENinCode plc(GENI)
Kapitalisasi Pasar: $33.74K
Per August 2026, GENinCode plc memiliki kapitalisasi pasar sebesar $33.74K. Ini menjadikan GENinCode plc sebagai perusahaan 41228th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar GENinCode plc dari 2021 hingga 2026
GENI dibandingkan dengan 5 teratas stocks paling populer
| Harga GENI |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.383T
|
+15,957,660,439.60%
|
|
|
|
|
$4.423T
|
+13,112,067,891.67%
|
|
|
|
|
$4.160T
|
+12,332,403,686.74%
|
|
|
|
|
$3.663T
|
+10,859,024,046.33%
|
|
|
|
|
$2.891T
|
+8,570,344,868.07%
|
